|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.96 EUR | +0.49% |
|
+10.37% | -29.50% |
| Apr. 23 | Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 29 | Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024 |
Pharma Mar, S.A. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was EUR 83.84 million compared to EUR 88.69 million a year ago. Revenue was EUR 141.4 million compared to EUR 140.33 million a year ago.
Net income was EUR 43.37 million compared to EUR 54.7 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.50% | 545M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.35B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
PHARMA MAR, S.A. 
